Healshape is a regenerative medicine startup headquartered in Lyon, France, founded in 2020 to develop 3D bioprinted breast implants for innovative breast reconstruction.
Subscribe to see Healshape’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Healshape is a healthcare technology company headquartered in Lyon, France. It has raised at least $13.1M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $6.3M in June 2022. Xcout tracks 16 named people at Healshape, including Hélène Lamielle (Chief Medical Officer).
As of 16 November 2026. Source: Xcout Intel.
10 more named people on record for Healshape, with roles, board committees and tenure — see the full roster →
At least $13.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $6.3M | 7 named | |
| Series A | $6.8M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 8 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Healshape's closest competitors — see the full list of competitors and alternatives →
Tiger Biotherapeutics Inc. is a regenerative medicine company that develops and provides advanced cellular, acellular, and matrix-like products (CAMPs) for wound care, aesthetics, and tissue science. The company serves healthcare providers and patients by offering solutions for tissue repair, wound closure, and reconstructive or cosmetic applications.
NovoThelium is a privately held biotechnology startup based in San Antonio, Texas, that is developing a tissue-engineered matrix for nipple regeneration following mastectomies.
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Precise Bio, Inc. is a clinical-stage regenerative medicine company that grows live organs for transplant using 3D bio-printing technology.
Eterna Regeneratives develops regenerative biomaterials and protein-derived scaffolds designed for mineralisation and tissue regeneration. The company's initial applications focus on oral health and enamel repair through professional consumer dental care formats, as well as bone regeneration for orthopaedic and bone grafting uses.
Frontier Bio develops engineered human tissues and vascular grafts to address cardiovascular disease and eliminate the need for organ donors and animal testing. The company provides tissue-engineered blood vessels for vascular grafts and commercializes human-based tissue models and services for preclinical testing.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Healshape? Suggest a correction · Work at Healshape? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.